DOACs may benefit patients at intermediate risk of AF
MDSpire News
October 2, 2026
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise:
4 Topic Commentaries
DOACs may benefit patients at intermediate risk of AF
Hugh Calkins, MD, FACC
Cardiac Electrophysiology
•Johns Hopkins Medicine
Fred M. Kusumoto, MD, FACC
Cardiac Electrophysiology
•Mayo Clinic, Jacksonville, FL
Howard E. LeWine, MD
Internal Medicine
•Harvard Health Publishing / Brigham and Women’s Hospital
Gregory Y. H. Lip, MD
Cardiology
•University of Birmingham
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.